Patent Application: Reducing Food Intake Using Plants
Summary
The USPTO has published a new patent application (US20260083809A1) detailing methods and compositions using plants like Dichrostachys glomerata or Cissus quadrangularis to reduce food intake or appetite in mammals. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.
What changed
This document is a patent application filed with the USPTO, not a regulatory rule or guidance. It describes methods and compositions utilizing specific plants (Dichrostachys glomerata or Cissus quadrangularis) to potentially reduce food intake, appetite, and other health markers such as GLP-1 levels, visceral fat, blood lipids, total cholesterol, and total glucose in mammals. The application was filed on September 26, 2024, under application number 18898575 and is designated for publication as US20260083809A1 on March 26, 2026.
As this is a patent application, it does not impose immediate compliance obligations on regulated entities. However, companies in the pharmaceutical, food manufacturing, or health and wellness sectors may wish to monitor the progress of this patent application and any subsequent granted patents. The claims within the patent, if granted, could impact the development and marketing of related products, potentially requiring licensing agreements or influencing product formulation strategies for those operating in related therapeutic areas.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS AND COMPOSITIONS FOR REDUCING FOOD INTAKE OR APPETITE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES
Application US20260083809A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari, Julius Enyoug Oben
Abstract
Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing food intake or appetite in a mammal is provided, where the composition comprises an effective amount of Cissus quadrangularis provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/87 A61P 3/04
Filing Date
2024-09-26
Application No.
18898575
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.